Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.12
-0.18 (-3.40%)
Apr 29, 2026, 11:55 AM EDT - Market open
Zura Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Mar '22 Mar 31, 2022 |
| Selling, General & Admin | 33.16 | 30.79 | 18.64 | 3.79 | 1.91 |
| Research & Development | 42.08 | 24.4 | 44 | 25.84 | 45 |
| Operating Expenses | 75.25 | 55.19 | 62.64 | 29.63 | 46.91 |
| Operating Income | -75.25 | -55.19 | -62.64 | -29.63 | -46.91 |
| Interest & Investment Income | 6.34 | 8 | 3.58 | 0.01 | - |
| Other Non Operating Income (Expenses) | 0.26 | -5.21 | 0.74 | -0.2 | - |
| EBT Excluding Unusual Items | -68.65 | -52.4 | -58.32 | -29.82 | -46.91 |
| Other Unusual Items | - | - | -2.24 | - | - |
| Pretax Income | -68.65 | -52.4 | -60.56 | -29.82 | -46.91 |
| Earnings From Continuing Operations | -68.65 | -52.4 | -60.56 | -29.82 | -46.91 |
| Minority Interest in Earnings | - | - | 0.2 | 1.74 | - |
| Net Income | -68.65 | -52.4 | -60.36 | -28.08 | -46.91 |
| Preferred Dividends & Other Adjustments | 30.7 | -7.02 | 8.88 | 7.26 | - |
| Net Income to Common | -99.35 | -45.39 | -69.24 | -35.33 | -46.91 |
| Shares Outstanding (Basic) | 94 | 75 | 33 | 0 | - |
| Shares Outstanding (Diluted) | 94 | 75 | 33 | 0 | - |
| Shares Change (YoY) | 25.43% | 127.05% | 14392.36% | - | - |
| EPS (Basic) | -1.06 | -0.60 | -2.09 | -154.88 | - |
| EPS (Diluted) | -1.06 | -0.60 | -2.09 | -154.88 | - |
| Free Cash Flow | -64.93 | -28.15 | -15.05 | -1.31 | -1.68 |
| Free Cash Flow Per Share | -0.69 | -0.38 | -0.46 | -5.75 | - |
| EBITDA | -75.2 | -55.18 | - | - | - |
| D&A For EBITDA | 0.05 | 0.01 | - | - | - |
| EBIT | -75.25 | -55.19 | -62.64 | -29.63 | -46.91 |
Source: S&P Capital IQ. Standard template.
Financial Sources.